Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Pediatr Cardiol ; 45(5): 976-985, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38485760

ABSTRACT

Adults with congenital heart disease (CHD) benefit from cardiology follow-up at recommended intervals of ≤ 2 years. However, benefit for children is less clear given limited studies and unclear current guidelines. We hypothesize there are identifiable risks for gaps in cardiology follow-up in children with CHD and that gaps in follow-up are associated with differences in healthcare utilization. Our cohort included children < 10 years old with CHD and a healthcare encounter from 2008 to 2013 at one of four North Carolina (NC) hospitals. We assessed associations between cardiology follow-up and demographics, lesion severity, healthcare access, and educational isolation (EI). We compared healthcare utilization based on follow-up. Overall, 60.4% of 6,969 children received cardiology follow-up within 2 years of initial encounter, including 53.1%, 58.1%, and 79.0% of those with valve, shunt, and severe lesions, respectively. Factors associated with gaps in care included increased drive time to a cardiology clinic (Hazard Ratio (HR) 0.92/15-min increase), EI (HR 0.94/0.2-unit increase), lesion severity (HR 0.48 for shunt/valve vs severe), and older age (HR 0.95/month if < 1 year old and 0.94/year if > 1 year old; p < 0.05). Children with a care gap subsequently had more emergency department (ED) visits (Rate Ratio (RR) 1.59) and fewer inpatient encounters and procedures (RR 0.51, 0.35; p < 0.05). We found novel factors associated with gaps in care for cardiology follow-up in children with CHD and altered health care utilization with a gap. Our findings demonstrate a need to mitigate healthcare barriers and generate clear cardiology follow-up guidelines for children with CHD.


Subject(s)
Heart Defects, Congenital , Humans , Heart Defects, Congenital/therapy , Male , Female , Child, Preschool , Risk Factors , Infant , Child , North Carolina/epidemiology , Health Services Accessibility , Retrospective Studies , Patient Acceptance of Health Care/statistics & numerical data , Infant, Newborn , Follow-Up Studies
2.
Pediatr Cardiol ; 44(7): 1520-1528, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37289278

ABSTRACT

The objective of this study was to assess the relationship of prenatal diagnosis of critical congenital heart disease (CHD) to preoperative and postoperative patient findings. Retrospective analysis of neonates with critical CHD who underwent cardiothoracic surgery at one of four centers in North Carolina between 2008 and 2013. Surgical data collected by sites for submission to the Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) and the North Carolina CHD Lifespan Database were queried. There were 715 patients with STS records; 558 linked to the NC-CHD database. Patients with prenatal diagnosis had a lower incidence of preoperative risk factors, including need for mechanical ventilation and presence of shock. However, prenatally diagnosed patients had worse short-term outcomes, including higher operative mortality, higher incidence of select postoperative complications, and longer LOS. There was no difference in one-year mortality. Our findings are consistent with current literature which suggests that prenatal diagnosis of critical CHD is associated with a more optimized preoperative clinical status. However, we found that patients with prenatal diagnoses had less favorable postoperative outcomes. This needs to be investigated further, but may be secondary to patient-specific factors, such as CHD disease severity.


Subject(s)
Cardiac Surgical Procedures , Heart Defects, Congenital , Infant, Newborn , Pregnancy , Female , Humans , Cardiac Surgical Procedures/adverse effects , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/surgery , Retrospective Studies , Prenatal Diagnosis , Risk Factors
3.
Pediatr Cardiol ; 44(2): 472-478, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36454266

ABSTRACT

Children with congenital heart defects (CHDs) are at risk for poor academic performance. The degree to which receipt of health care services is associated with adverse academic outcomes is not known. We examined the association between episodes of cardiac care and third-grade performance in children with CHD. We identified subjects between 1/1/2008 and 4/30/2012 among 5 centers in North Carolina. We classified children by CHD type and linked subjects to the state educational records. Any inpatient or outpatient cardiac encounter on a date of service was considered an encounter. We calculated the number of encounters by adding the number of inpatient or outpatient cardiac visits prior to the date of the end-of-grade (EOG) tests. We estimated the odds of failing third-grade reading or math EOG tests by episodes of care stratified at the 50th percentile, controlling for CHD type, maternal education, sex, race/ethnicity, birth weight, and gestational age. A total of 184 children had third-grade EOG scores linked to health care records. The median number of episodes of care was 4 (range: 1-60). Those with visits ˃ 50th percentile (> 4 encounters/year over the 4.3 year observation period) had 2.09 (95% CI 1.04, 4.21) greater odds of failing the math EOG compared to those ≤ 50th percentile (1-4 encounters). The third-grade math score declined by 1.5 points (P < 0.008) for every 10 episodes of care. There was no association of episodes of care on third-grade reading performance. Children with CHD with > 4 episodes of cardiac care/year may be at risk for delays in third-grade academic performance. Strategies to minimize school absenteeism may improve academic success in this population.


Subject(s)
Academic Performance , Heart Defects, Congenital , Humans , Child , Educational Status , Heart Defects, Congenital/epidemiology , Heart Defects, Congenital/therapy , Schools , North Carolina/epidemiology
4.
J Am Heart Assoc ; 9(14): e016400, 2020 07 21.
Article in English | MEDLINE | ID: mdl-32654582

ABSTRACT

Background Little is known about the contemporary mortality experience among adults with congenital heart disease (CHD). The objectives of this study were to assess the age at death, presence of cardiovascular comorbidities, and most common causes of death among adults with CHD in a contemporary cohort within the United States. Methods and Results Patients with CHD who had a healthcare encounter between 2008 and 2013 at 1 of 5 comprehensive CHD centers in North Carolina were identified by International Classification of Diseases, Ninth Revision (ICD-9), code. Only patients who could be linked to a North Carolina death certificate between 2008 and 2016 and with age at death ≥20 years were included. Median age at death and underlying cause of death based on death certificate data were analyzed. The prevalence of acquired cardiovascular risk factors was determined from electronic medical record data. Among the 629 included patients, the median age at death was 64.2 years. Those with severe CHD (n=157, 25%), shunts (n=202, 32%), and valvular lesions (n=174, 28%) had a median age at death of 46.0, 65.0, and 73.3 years, respectively. Cardiovascular death was most common in adults with severe CHD (60%), with 40% of those deaths caused by CHD. Malignancy and ischemic heart disease were the most common causes of death in adults with nonsevere CHD. Hypertension and hyperlipidemia were common comorbidities among all CHD severity groups. Conclusions The most common underlying causes of death differed by lesion severity. Those with severe lesions most commonly died from underlying CHD, whereas those with nonsevere disease more commonly died from non-CHD causes.


Subject(s)
Cause of Death , Heart Defects, Congenital/mortality , Aged , Aged, 80 and over , Cohort Studies , Comorbidity , Female , Humans , Male , North Carolina/epidemiology , Risk Factors
5.
N Engl J Med ; 372(11): 1055, 2015 Mar 12.
Article in English | MEDLINE | ID: mdl-25760358
6.
N C Med J ; 75(2): 146-8, 2014.
Article in English | MEDLINE | ID: mdl-24663142

ABSTRACT

Over the past 2 decades, use of noninvasive cardiovascular imaging has increased dramatically. This article provides a brief synopsis of the current state of several technologies-- echocardiography, cardiac magnetic resonance imaging, and cardiac computed tomography--as well as a glimpse at future possibilities in cardiac imaging.


Subject(s)
Cardiac Imaging Techniques/methods , Heart/diagnostic imaging , Echocardiography/methods , Humans , Magnetic Resonance Imaging/methods , Myocardial Perfusion Imaging/methods , Radionuclide Angiography/methods , Tomography, X-Ray Computed/methods
7.
Can J Urol ; 20(6): 7064-6, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24331350

ABSTRACT

Retroperitoneal fibrosis (RPF) is a rarely occurring disease process characterized by the development of fibrous plaques that encase retroperitoneal organs and major vessels. The most common sequelae is obstructive uropathy secondary to ureteral compression. Ureterolysis with intraperitoneal transposition and omental wrapping has historically been a popularized means to relieve ureteral obstruction. We present the case of a 47-year-old man with bilateral hydronephrosis secondary to RPF. Due to insufficient length of omentum, we report the first documented use of SurgiWrap to wrap the ureters to minimize the future possibility of recurrent/continued fibrosis, compression, and ureteral obstruction.


Subject(s)
Polyesters/therapeutic use , Tissue Adhesions/prevention & control , Ureteral Obstruction/surgery , Absorbable Implants , Humans , Hydronephrosis/etiology , Male , Middle Aged , Retroperitoneal Fibrosis/complications , Ureteral Obstruction/etiology
8.
Urology ; 82(6): 1416-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23972342

ABSTRACT

Clear cell sarcoma of the kidney (CCSK) is an uncommon neoplasm that accounts for less than 5% of all pediatric renal tumors. Compared with Wilms' tumor, CCSK has a higher rate of relapse, greater propensity for bone metastasis, and poorer overall survival. We present the case of a 19-month-old boy with a large renal mass diagnosed incidentally by ultrasonography during surveillance for vesicoureteral reflux. This report describes the rare occurrence of an incidental radiologic capture of CCSK and provides a brief review of disease pathology.


Subject(s)
Kidney Neoplasms/diagnostic imaging , Sarcoma, Clear Cell/diagnostic imaging , Bone Neoplasms/secondary , Combined Modality Therapy , Humans , Hydronephrosis/diagnostic imaging , Incidental Findings , Infant , Kidney/diagnostic imaging , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Male , Nephrectomy , Sarcoma, Clear Cell/pathology , Sarcoma, Clear Cell/surgery , Ultrasonography , Vesico-Ureteral Reflux/diagnostic imaging
9.
Pediatr Cardiol ; 32(8): 1147-57, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21728077

ABSTRACT

We aimed to assess the frequency of chromosomal abnormalities among infants with congenital heart defects (CHDs) in an analysis of population-based surveillance data. We reviewed data from the Metropolitan Atlanta Congenital Defects Program, a population-based birth-defects surveillance system, to assess the frequency of chromosomal abnormalities among live-born infants and fetal deaths with CHDs delivered from January 1, 1994, to December 31, 2005. Among 4430 infants with CHDs, 547 (12.3%) had a chromosomal abnormality. CHDs most likely to be associated with a chromosomal abnormality were interrupted aortic arch (type B and not otherwise specified; 69.2%), atrioventricular septal defect (67.2%), and double-outlet right ventricle (33.3%). The most common chromosomal abnormalities observed were trisomy 21 (52.8%), trisomy 18 (12.8%), 22q11.2 deletion (12.2%), and trisomy 13 (5.7%). In conclusion, in our study, approximately 1 in 8 infants with a CHD had a chromosomal abnormality. Clinicians should have a low threshold at which to obtain testing for chromosomal abnormalities in infants with CHDs, especially those with certain types of CHDs. Use of new technologies that have become recently available (e.g., chromosomal microarray) may increase the identified contribution of chromosomal abnormalities even further.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Aberrations/statistics & numerical data , Heart Defects, Congenital/genetics , Humans , Microarray Analysis , Prevalence , Trisomy/genetics , United States/epidemiology
10.
Am J Med Genet A ; 155A(3): 555-64, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21337694

ABSTRACT

Nonsyndromic atrioventricular septal defects (AVSDs) are serious congenital heart defects for which information on prevalence and descriptive characteristics based on large, geographically, and ethnically diverse populations has been limited. To describe the birth prevalence and phenotype of nonsyndromic AVSDs, we used data from the National Birth Defects Prevention Study (NBDPS), a multisite, population-based case-control study aimed at identifying genetic and environmental risk factors for birth defects. For this analysis, infants born during the period 1997-2005 and meeting the NBDPS case definition for AVSDs were included. Infants with an AVSD associated with recognized or strongly suspected chromosomal abnormalities or single-gene disorders (syndromic case infants) were excluded. We identified 302 infants with a nonsyndromic AVSD for a birth prevalence of 0.83/10,000 livebirths. Over 20% of infants with an AVSD had an additional major birth defect, with gastrointestinal, renal or urinary, and central nervous system defects being the most common. A lower prevalence of AVSDs was seen among infants born to Hispanic mothers compared with those born to non-Hispanic White mothers [prevalence ratio = 0.63 (95% confidence interval: 0.46-0.86)]. Understanding the prevalence of nonsyndromic AVSDs, demographic factors associated with their occurrence, and associated defects could help guide clinical care, as well as contribute to a better understanding of pathogenesis.


Subject(s)
Heart Septal Defects, Ventricular/epidemiology , Heart Septal Defects, Ventricular/prevention & control , Adult , Demography , Female , Heart Septal Defects, Ventricular/classification , Humans , Infant, Newborn , Male , Pregnancy , Prevalence , Syndrome , United States/epidemiology , Young Adult
11.
Can J Urol ; 18(1): 5564-7, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21333055

ABSTRACT

INTRODUCTION: Osseous metaplasia is a rare histologic feature not often associated with renal cell carcinoma; there are only 14 reported cases and just four associated with the clear cell variant. We report the case of a 48-year-old female who presented with diffuse abdominal pain. MATERIALS AND METHODS: We reviewed the case of woman who underwent a robotic assisted partial nephrectomy for an enhancing renal mass. Histologic analyses and immunostains were reviewed by multiple pathologists. RESULTS: CT imaging revealed a 1.8 cm irregular enhancing exophytic mass with calcifications. The patient subsequently underwent robotic assisted laparoscopic partial nephrectomy. The final pathologic diagnosis was clear cell carcinoma with metaplastic bone formation. CONCLUSION: While the prognostic significance of bone metaplasia occurrence in renal cell carcinoma is controversial, such that can safely be managed with partial nephrectomy.


Subject(s)
Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Nephrectomy/methods , Ossification, Heterotopic/pathology , Carcinoma, Renal Cell/surgery , Female , Humans , Kidney Neoplasms/surgery , Metaplasia , Middle Aged , Robotics
12.
Can J Urol ; 17(3): 5190-4, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20566012

ABSTRACT

OBJECTIVES: To report the initial clinical experience using a hybrid technique combining holmium laser ablation of the prostate (HoLAP) and holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). METHODS: A total of 18 patients with documented moderate to severe LUTS underwent the hybrid technique. Baseline characteristics were documented for all patients. Operative and resection times, as well as intra and perioperative complications, were recorded. Additionally, changes in American Urological Association symptom index (AUA-SI) and quality of life (QoL) scores and serum prostate-specific antigen (PSA) values were recorded both pre and postoperatively. RESULTS: All patients experienced significant improvements in their AUA-SI and QoL scores, with a mean decrease in PSA of 74.6% postoperatively. There were no reported complications with this technique and the average resection time (48.2 min) was decreased in comparison to those reported for HoLAP or HoLEP monotherapies. CONCLUSIONS: This is the first report of surgical therapy for BPH involving two different holmium laser therapies. This hybrid technique offers tissue for pathologic analysis in comparison to HoLAP, and an improved learning curve and decreased complication rate in comparison to HoLEP. Additional studies are warranted to validate this data.


Subject(s)
Laser Therapy , Lasers, Solid-State/therapeutic use , Prostatectomy/methods , Prostatic Hyperplasia/surgery , Prostatism/surgery , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Pilot Projects , Prostatic Hyperplasia/complications , Prostatism/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...